Table 6. Number of 3-year survivors and 5-year survivors according to clinical factors.
| Clinical factor | No. of patients | No. of 3-year survivors | No. of 5-year survivors |
|---|---|---|---|
| Total | 38 | 10 | 4 |
| Surgical procedure | |||
| Sublob. | 10 | 1 | 0 |
| Over lob. | 28 | 9 | 4 |
| EGFR mutation | |||
| Positive | 6 | 2 | 1 |
| Negative or unknown | 32 | 8 | 3 |
| T status | |||
| T1–2 | 20 | 3 | 2 |
| T3–4 | 18 | 7 | 2 |
| N status | |||
| Negative | 16 | 6 | 3 |
| Positive | 22 | 4 | 1 |
| cM status | |||
| cM0 | 11 | 5 | 2 |
| cM1a | 8 | 0 | 0 |
| cM1b | 13 | 4 | 1 |
| cM1c | 6 | 1 | 1 |
| Meta site | |||
| With brain | 5 | 2 | 1 |
| Without brain | 14 | 3 | 1 |
| Local control | |||
| Controlled | 13 | 5 | 2 |
| Uncontrolled | 6 | 0 | 0 |
| M category | |||
| M better | 24 | 10 | 4 |
| M worse | 14 | 0 | 0 |
Sublob, sublobar resection; lob., lobectomy; EGFR, epidermal growth factor receptor.